; (4) require that patients have access to licensed substance use disorder treatment services, including health care providers and physicians, for inpatient and outpatient care; (5) identify and develop strategies for States to ensure that all substance use disorder patients receive a medical assessment, including for co-occurring mental health issues and infectious diseases; (6) require States to implement a process to ensure that residential treatment provider qualifications are verified by the single State agency serving as the primary regulator in the State for substance use disorder treatment services (as required in paragraph (13)) or by an independent third party with the necessary competencies to use evidence-based patient placement assessment tools and nationally-recognized program standards, as applicable; (7) ensure that patients receiving substance use disorder treatment have access directly, by referral, or in such other manner as determined by the Secretary, to all Federally-approved medication-assisted treatments for substance use disorder; (8) develop standards for data reporting and require compilation of Statewide reports; (9) develop standards for licensed providers to ensure all patients receive an outpatient treatment and discharge plan; (10) develop standards for the certification of recovery residences that have an ongoing economic relationship with any commercial substance use disorder treatment service, including any relationship with any such service that includes receiving or making referrals for substance use disorder treatment, including— (A) application, inspection, and renewal procedures for recovery residences; (B) fire, safety, and health standards; (C) standards for equipping residences with naloxone and training residence owners, operators, and employees in the administration of naloxone; (D) standards for recovery residence owners and operators